The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcgrath John since 2007.
The trader's CIK number is 1205442.
At the time of the last reporting, Mcgrath John was the EXC.112.VP CFO of Atara Biotherapeutics, Inc.. (stock ticker symbol ATRA).
Also see all insider trading activities at Atara Biotherapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | NWK | 0 | $0 | 50,000 | $559,487 | 50,000 | $150,000 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | ATRA | 0 | $0 | 88,000 | $2,360,552 | 35,132 | $330,000 |
2017 | ATRA | 0 | $0 | 55,200 | $1,025,847 | 34,528 | $0 |
2016 | ATRA | 0 | $0 | 21,395 | $364,519 | 42,008 | $0 |
2015 | ATRA | 0 | $0 | 32,000 | $1,436,280 | 86,361 | $0 |
1. Network Equipment Technologies Inc (NWK)
2. Atara Biotherapeutics, Inc. (ATRA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-11-12 | NWK | Option Ex | 25,000 | 3.00 | 75,000 |
2007-11-12 | NWK | Sale | 25,000 | 12.31 | 307,700 |
2007-08-17 | NWK | Sale | 6,718 | 10.25 | 68,859 |
2007-08-16 | NWK | Sale | 14,000 | 10.01 | 140,070 |
2007-08-17 | NWK | Option Ex | 6,718 | 3.00 | 20,154 |
2007-08-16 | NWK | Option Ex | 14,000 | 3.00 | 42,000 |
2007-08-15 | NWK | Sale | 4,282 | 10.01 | 42,858 |
2007-08-15 | NWK | Option Ex | 4,282 | 3.00 | 12,846 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-03-20 | ATRA | Sale | 3,000 | 38.83 | 116,490 |
2018-03-19 | ATRA | Sale | 3,000 | 41.99 | 125,970 |
2018-02-15 | ATRA | Option Ex | 5,132 | .00 | 0 |
2018-02-15 | ATRA | Sale | 6,500 | 46.77 | 304,005 |
2018-02-16 | ATRA | Sale | 6,500 | 47.51 | 308,782 |
2018-01-11 | ATRA | Sale | 3,500 | 20.77 | 72,695 |
2018-01-12 | ATRA | Sale | 33,500 | 23.66 | 792,610 |
2018-01-12 | ATRA | Option Ex | 30,000 | 11.00 | 330,000 |
2017-12-29 | ATRA | Sale | 32,000 | 20.00 | 640,000 |
2017-11-15 | ATRA | Option Ex | 7,697 | .00 | 0 |
2017-08-15 | ATRA | Option Ex | 7,697 | .00 | 0 |
2017-08-16 | ATRA | Sale | 2,100 | 14.39 | 30,219 |
2017-08-15 | ATRA | Sale | 2,100 | 14.23 | 29,883 |
2017-05-15 | ATRA | Option Ex | 8,633 | .00 | 0 |
2017-05-15 | ATRA | Sale | 2,000 | 14.95 | 29,900 |
2017-05-16 | ATRA | Sale | 2,000 | 15.27 | 30,540 |
2017-03-22 | ATRA | Sale | 7,500 | 20.27 | 152,025 |
2017-03-23 | ATRA | Sale | 6,500 | 21.08 | 137,020 |
2017-03-10 | ATRA | Sale | 24,000 | 20.00 | 480,000 |
2017-02-21 | ATRA | Sale | 9,000 | 15.14 | 136,260 |
2017-02-15 | ATRA | Option Ex | 10,501 | .00 | 0 |
2016-11-15 | ATRA | Option Ex | 10,503 | .00 | 0 |
2016-11-10 | ATRA | Sale | 2,500 | 20.30 | 50,750 |
2016-11-11 | ATRA | Sale | 2,500 | 19.37 | 48,425 |
2016-10-11 | ATRA | Sale | 2,500 | 18.52 | 46,300 |
2016-10-12 | ATRA | Sale | 2,500 | 16.41 | 41,025 |
2016-08-15 | ATRA | Option Ex | 10,501 | .00 | 0 |
2016-05-16 | ATRA | Option Ex | 10,503 | .00 | 0 |
2016-05-16 | ATRA | Sale | 5,395 | 15.77 | 85,079 |
2016-02-16 | ATRA | Option Ex | 10,501 | .00 | 0 |
2016-02-16 | ATRA | Sale | 6,000 | 15.49 | 92,940 |
2015-11-30 | ATRA | Sale | 6,000 | 40.00 | 240,000 |
2015-11-16 | ATRA | Option Ex | 10,502 | .00 | 0 |
2015-08-17 | ATRA | Option Ex | 10,502 | .00 | 0 |
2015-08-18 | ATRA | Sale | 6,000 | 49.38 | 296,280 |
2015-06-15 | ATRA | Sale | 10,000 | 50.00 | 500,000 |
2015-05-29 | ATRA | Sale | 10,000 | 40.00 | 400,000 |
2015-05-15 | ATRA | Option Ex | 65,357 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcgrath John (EXC.112.VP CFO of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.